BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Du Y, Wang B, Jiang X, Cao J, Yu J, Wang Y, Wang X, Liu H. Identification and Validation of a Stromal EMT Related LncRNA Signature as a Potential Marker to Predict Bladder Cancer Outcome. Front Oncol 2021;11:620674. [PMID: 33747932 DOI: 10.3389/fonc.2021.620674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang S, Li D, Zhuang L, Zhang J, Wu J. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients. Front Med 2022;9:850343. [DOI: 10.3389/fmed.2022.850343] [Reference Citation Analysis]
2 Du Y, Sui Y, Cao J, Jiang X, Wang Y, Yu J, Wang B, Wang X, Xue B. Dynamic Changes in Myofibroblasts Affect the Carcinogenesis and Prognosis of Bladder Cancer Associated With Tumor Microenvironment Remodeling. Front Cell Dev Biol 2022;10:833578. [DOI: 10.3389/fcell.2022.833578] [Reference Citation Analysis]
3 Choi HY, Ahn J, Kwon H, Yim JH, Lee D, Choi J. Citromycin Isolated from the Antarctic Marine-Derived Fungi, Sporothrix sp., Inhibits Ovarian Cancer Cell Invasion via Suppression of ERK Signaling. Marine Drugs 2022;20:275. [DOI: 10.3390/md20050275] [Reference Citation Analysis]
4 Cai H, Chen H, Huang Q, Zhu JM, Ke ZB, Lin YZ, Zheng QS, Wei Y, Xu N, Xue XY. Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients. Pathol Oncol Res 2021;27:1609941. [PMID: 34776794 DOI: 10.3389/pore.2021.1609941] [Reference Citation Analysis]
5 Hu J, Lai C, Shen Z, Yu H, Lin J, Xie W, Su H, Kong J, Han J. A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs. Front Oncol 2022;12:833763. [DOI: 10.3389/fonc.2022.833763] [Reference Citation Analysis]
6 Xu Z, Chen H, Sun J, Mao W, Chen S, Chen M. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence. Bioengineered 2021;12:11108-25. [PMID: 34738881 DOI: 10.1080/21655979.2021.2000122] [Reference Citation Analysis]
7 Yu Q, Zhao L, Yan XX, Li Y, Chen XY, Hu XH, Bu Q, Lv XP. Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma. World J Surg Oncol 2022;20:183. [PMID: 35668494 DOI: 10.1186/s12957-022-02595-1] [Reference Citation Analysis]
8 Cui Y, Zhou Z, Chai Y, Che X, Zhang Y. Identification of a Nomogram from Ferroptosis-Related Long Noncoding RNAs Signature to Analyze Overall Survival in Patients with Bladder Cancer. J Oncol 2021;2021:8533464. [PMID: 34484338 DOI: 10.1155/2021/8533464] [Reference Citation Analysis]
9 Yang X, Niu S, Liu J, Fang J, Wu Z, Ling S, Di G, Jiang X. Identification of an epithelial-mesenchymal transition-related lncRNA prognostic signature for patients with glioblastoma. Sci Rep 2021;11:23694. [PMID: 34880375 DOI: 10.1038/s41598-021-03213-y] [Reference Citation Analysis]
10 Mirzaei S, Paskeh MDA, Hashemi F, Zabolian A, Hashemi M, Entezari M, Tabari T, Ashrafizadeh M, Raee P, Aghamiri S, Aref AR, Leong HC, Kumar AP, Samarghandian S, Zarrabi A, Hushmandi K. Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies. Life Sci 2021;:119948. [PMID: 34520771 DOI: 10.1016/j.lfs.2021.119948] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]